Treatment
Recombinant human erythropoietin clinical trials
We’re tracking 4 recruiting studies that include Recombinant human erythropoietin, each written for real people, not researchers, below.
Recruiting studies
- NCT05353348Recruiting
Program to treat mild anemia around heart surgery
This trial tests a combined treatment plan to improve anemia (low blood count/iron levels) before and around the time of major elective heart surgery. It may help reduce the need for blood transfusions and support safer recovery.
Hangzhou, ZhejiangAges 18 years+ - NCT06968936Recruiting
Long-term outcomes of pre-surgery iron therapy
This study looks at long-term results of giving iron before major heart surgery to people with low iron levels. It aims to see if this treatment helps recovery and outcomes.
Hangzhou, ZhejiangAges 18–85 - NCT07586904RecruitingEarly Phase 1
New Immunotherapy Combination for Advanced Melanoma
This trial tests a combination of two drugs (cadonilimab and interferon) given before surgery to treat advanced melanoma that has spread to nearby lymph nodes or one distant site. The goal is to shrink tumors and improve chances of successful surgery and long-term survival.
Xi'anAges 18–75 - NCT05857891Recruiting
Erythropoietin to help clear lung fluid in ARDS
This trial tests whether erythropoietin (EPO), a medicine that affects red blood cell production, can help clear extra fluid from the lungs in people with acute respiratory distress syndrome (ARDS). If it works, it could improve breathing and reduce lung fluid buildup during critical illness.
Wenzhou, ZhejiangAges 18 years+
What Recombinant human erythropoietin is being studied for
Conditions with recruiting Recombinant human erythropoietin studies.
Common questions
- Are there clinical trials studying Recombinant human erythropoietin?
- Yes. Clin2 currently lists 4 recruiting studies that include Recombinant human erythropoietin, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Recombinant human erythropoietin trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Recombinant human erythropoietin an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Recombinant human erythropoietin or a specific trial is right for you.
Related treatments
- Recombinant Human Growth Hormone
- Recombinant Human Adenovirus Type 5
- Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1
- Human Umbilical Cord Mesenchymal Stem Cells
- Recombinant Granulocyte Colony-Stimulating Factor
- Recombinant Respiratory Syncytial Virus Vaccine
- Human albumin
- Erythropoietin
- Human Dopaminergic Progenitor Cells
- Human Urinary Kallidinogenase
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.